JP2019507113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507113A5 JP2019507113A5 JP2018534626A JP2018534626A JP2019507113A5 JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5 JP 2018534626 A JP2018534626 A JP 2018534626A JP 2018534626 A JP2018534626 A JP 2018534626A JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5
- Authority
- JP
- Japan
- Prior art keywords
- biodegradable
- disease
- antigen
- subject
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021105106A JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662274711P | 2016-01-04 | 2016-01-04 | |
| US62/274,711 | 2016-01-04 | ||
| PCT/US2017/012173 WO2017120222A1 (en) | 2016-01-04 | 2017-01-04 | Particles encapsulating fusion proteins containing linked epitopes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Division JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507113A JP2019507113A (ja) | 2019-03-14 |
| JP2019507113A5 true JP2019507113A5 (enExample) | 2020-02-06 |
| JP6904959B2 JP6904959B2 (ja) | 2021-07-21 |
Family
ID=59274014
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534626A Active JP6904959B2 (ja) | 2016-01-04 | 2017-01-04 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A Pending JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A Pending JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20190365656A1 (enExample) |
| EP (1) | EP3400069A4 (enExample) |
| JP (4) | JP6904959B2 (enExample) |
| CA (1) | CA3009799A1 (enExample) |
| IL (2) | IL260296B2 (enExample) |
| WO (1) | WO2017120222A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013163176A1 (en) | 2012-04-23 | 2013-10-31 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| CA2907915C (en) | 2013-04-03 | 2023-03-07 | Allertein Therapeutics, Llc | Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components |
| EP3247384B1 (en) * | 2015-01-14 | 2023-10-04 | The Regents of the University of Colorado, a body corporate | In vitro method of diagnosis of type 1 diabetes with insulin mimotopes |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| SG11201808552XA (en) | 2016-05-18 | 2018-10-30 | Cue Biopharma Inc | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN110325205B (zh) | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| KR20240005989A (ko) | 2017-03-15 | 2024-01-12 | 큐 바이오파마, 인크. | 면역 반응을 조절하는 방법 |
| CN111566214B (zh) * | 2017-07-06 | 2024-03-08 | 日东纺绩株式会社 | 抗人IgG4单克隆抗体及利用该抗体的人IgG4测定试剂 |
| EP3678677A4 (en) * | 2017-09-07 | 2021-06-16 | Cue Biopharma, Inc. | ANTIGEN-PRESENTING POLYPEPTIDES AND METHOD FOR THEIR USE |
| WO2019131769A1 (ja) * | 2017-12-26 | 2019-07-04 | 公立大学法人名古屋市立大学 | 新規抗ｐａｄ４抗体 |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| CN110041408B (zh) * | 2018-01-16 | 2021-05-18 | 华中科技大学 | 一种小分子多肽及其在制备防治帕金森综合症药物中的应用 |
| CA3102032A1 (en) | 2018-06-05 | 2019-12-12 | Anji Pharma (Us) Llc | Compositions and methods for treating pancreatitis |
| EP3807294B1 (en) * | 2018-06-13 | 2026-01-14 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. | Peptides having inhibitory activity on muscarinic receptor m3 |
| AU2020316005A1 (en) * | 2019-07-19 | 2022-02-24 | The Regents Of The University Of Michigan | Compositions and methods for treating autoimmune disorders |
| EP4138907A4 (en) * | 2020-04-20 | 2024-08-21 | The General Hospital Corporation | IMMUNOGENIC COMPOSITION OF CORONAVIRUS WITH EPITOPES HAVING HIGH NETWORK SCORE |
| IL296209A (en) | 2020-05-12 | 2022-11-01 | Cue Biopharma Inc | Multimeric t-cell modulatory polypeptides and methods of using them |
| IT202000010888A1 (it) * | 2020-05-13 | 2021-11-13 | Consiglio Nazionale Ricerche | Nanovescicole di mielina e loro impieghi |
| JP2023541366A (ja) | 2020-09-09 | 2023-10-02 | キュー バイオファーマ， インコーポレイテッド | １型真性糖尿病（ｔ１ｄ）を治療するためのｍｈｃクラスｉｉ ｔ細胞調節多量体ポリペプチド及びその使用方法 |
| GB202017119D0 (en) * | 2020-10-28 | 2020-12-09 | Oxford Vacmedix Uk Ltd | Polypeptides for cancer treatment |
| IL307722A (en) | 2021-04-16 | 2023-12-01 | Cour Pharmaceuticals Dev Company Inc | A method of monitoring the existence of immunological tolerance |
| EP4337322A1 (en) * | 2021-05-11 | 2024-03-20 | Oxford Vacmedix UK Ltd. | Vaccine formulation comprising recombinant overlapping peptides and native proteins |
| JPWO2023282293A1 (enExample) * | 2021-07-07 | 2023-01-12 | ||
| WO2023070104A1 (en) | 2021-10-21 | 2023-04-27 | Cour Pharmaceuticals Development Company Inc. | Treatment of primary biliary cholangitis (pbc) with tolerizing nanoparticles |
| AR127755A1 (es) * | 2021-11-24 | 2024-02-28 | Cour Pharmaceuticals Dev Company Inc | Preparación de nanopartículas que inducen tolerancia para el tratamiento de la alergia al maní |
| CN118922202A (zh) * | 2022-03-24 | 2024-11-08 | 尤利乌斯·马克西米利安维尔茨堡大学 | MHC Ib介导的胰岛抗原特异性免疫抑制作为1型糖尿病的新型疗法 |
| TW202400801A (zh) | 2022-04-29 | 2024-01-01 | 美商庫爾製藥發展公司股份有限公司 | 用於克服治療性載體及蛋白質之免疫原性之耐受性免疫修飾奈米粒子 |
| CN115541872A (zh) * | 2022-09-22 | 2022-12-30 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种pd-l1检测试剂盒及其检测方法 |
| WO2024086706A1 (en) | 2022-10-19 | 2024-04-25 | Cour Pharmaceuticals Development Company Inc. | Treatment of peanut allergy with tolerizing nanoparticles |
| CN115771883B (zh) * | 2022-11-28 | 2024-02-23 | 淮阴工学院 | 从酿酒酵母发酵液中提取的蛋白酶a在化学法合成纳米硒形貌控制和稳定性影响中的用途 |
| WO2024206202A1 (en) | 2023-03-24 | 2024-10-03 | Cour Pharmaceuticals Development Company Inc. | Tolerizing immune modifying nanoparticles for myasthenia gravis treatment |
| KR20260016937A (ko) | 2023-05-23 | 2026-02-04 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. | 원발성 담즙성 담관염의 치료를 위한 관용화 나노입자의 제조 |
| TW202500576A (zh) | 2023-05-25 | 2025-01-01 | 美商庫爾製藥發展公司股份有限公司 | 以免疫耐受性(tolerizing)奈米粒子治療1型糖尿病(t1d) |
| EP4753730A1 (en) * | 2023-08-01 | 2026-06-10 | Diamante Srl | Composition and methods for treating multiple sclerosis |
| WO2025043196A2 (en) * | 2023-08-24 | 2025-02-27 | The Trustees Of Indiana University | Anti-cancer peptides, and methods and uses thereof |
| WO2025199149A1 (en) | 2024-03-18 | 2025-09-25 | Cour Pharmaceuticals Development Company Inc. | Sting agonism for antigen specific tolerance |
| WO2026019942A2 (en) | 2024-07-16 | 2026-01-22 | Cour Pharmaceuticals Development Company Inc. | Tolerizing immune modifying nanoparticles for treatment of narcolepsy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1135408T3 (da) * | 1998-12-04 | 2012-01-23 | Biogen Idec Inc | HBV-kerneantigenpartikler med multipelle immunogene komponenter, som er bundne via peptidligander |
| CA2410510A1 (en) * | 2000-06-02 | 2001-12-13 | Memorial Sloan-Kettering Cancer Center | Artificial antigen presenting cells and methods of use thereof |
| US20060222656A1 (en) * | 2005-04-01 | 2006-10-05 | University Of Maryland, Baltimore | MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
| WO2009022236A2 (en) * | 2007-08-16 | 2009-02-19 | Tripep Ab | Immunogen platform |
| US8691771B2 (en) * | 2010-05-21 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Bi-specific fusion proteins for tissue repair |
| US20120070493A1 (en) * | 2010-08-23 | 2012-03-22 | Selecta Biosciences, Inc. | Targeted multi-epitope dosage forms for induction of an immune response to antigens |
| MX357202B (es) * | 2012-02-16 | 2018-06-28 | Vlp Therapeutics Llc | Composicion de particula tipo virus. |
| KR102283760B1 (ko) * | 2012-06-21 | 2021-08-03 | 노쓰웨스턴유니버시티 | 펩티드 접합된 입자 |
| DK3033102T4 (da) * | 2013-08-13 | 2024-02-26 | Univ Northwestern | Peptidkonjugerede partikler |
| WO2017139498A1 (en) * | 2016-02-09 | 2017-08-17 | Cour Pharmaceuticals Development Company Inc. | Timps encapsulating japanese cedar pollen epitopes |
-
2017
- 2017-01-04 US US16/067,867 patent/US20190365656A1/en not_active Abandoned
- 2017-01-04 IL IL260296A patent/IL260296B2/en unknown
- 2017-01-04 CA CA3009799A patent/CA3009799A1/en active Pending
- 2017-01-04 EP EP17736249.8A patent/EP3400069A4/en active Pending
- 2017-01-04 WO PCT/US2017/012173 patent/WO2017120222A1/en not_active Ceased
- 2017-01-04 JP JP2018534626A patent/JP6904959B2/ja active Active
- 2017-01-04 IL IL304580A patent/IL304580B1/en unknown
-
2021
- 2021-06-24 JP JP2021105106A patent/JP7333360B2/ja active Active
-
2023
- 2023-06-12 US US18/333,103 patent/US20240122864A1/en active Pending
- 2023-08-14 JP JP2023132166A patent/JP7730867B2/ja active Active
-
2025
- 2025-08-18 JP JP2025136021A patent/JP2025181835A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016053091A5 (enExample) | ||
| Choi et al. | Effective delivery of antigen–encapsulin nanoparticle fusions to dendritic cells leads to antigen-specific cytotoxic T cell activation and tumor rejection | |
| JP2019522490A5 (enExample) | ||
| JP2019511222A5 (enExample) | ||
| HRP20241228T1 (hr) | T stanični receptori i imunološka terapija uporabom istih protiv pram pozitivnih karcinoma | |
| JP2010516290A5 (enExample) | ||
| JP2013181034A5 (enExample) | ||
| JP2019507135A5 (enExample) | ||
| JP2011521662A5 (enExample) | ||
| JP2016519932A5 (enExample) | ||
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| JP2017531642A5 (enExample) | ||
| JP2012518425A5 (enExample) | ||
| JP2014221758A5 (enExample) | ||
| JP2017507936A5 (enExample) | ||
| JP2015143226A5 (enExample) | ||
| RU2017124141A (ru) | Растворимый универсальный усиливающий adcc синтетический слитный ген, пептидная технология и их применение | |
| JP7656627B2 (ja) | 変異表面糖タンパク質担体のための免疫化スキーム | |
| JP2016504993A5 (enExample) | ||
| RS63580B1 (sr) | Humanizovana antitela protiv clever-1 i njihova primena | |
| JPWO2020059847A5 (enExample) | ||
| JP2017504321A5 (enExample) | ||
| WO2017072299A1 (en) | Polypeptides against il-23 | |
| JP2016508143A5 (enExample) | ||
| CN118475603A (zh) | 高亲和力抗EGFP和抗SARS-CoV-2 vNAR单域抗体及其用途 |